Source:http://linkedlifedata.com/resource/pubmed/id/18322220
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2008-3-6
|
pubmed:abstractText |
In spite of the extensive research in the field of gene therapy, host immune responses continue to be the major barrier in translating basic research to clinical practice. Helper-dependent adenoviral (HD-Ad) vectors show great potential for pulmonary gene therapy, but the knowledge of pulmonary immune responses toward these vectors is very limited. In this study, we show that HD-Ad vectors are potent stimulators of dendritic cell (DC) maturation, thus leading to stimulation of T cell proliferation with approximately 6% of naive CD4(+) T cells from pulmonary mediastinal lymph node responding to HD-Ad-treated DCs. In contrast to the belief that HD-Ad vectors are unable to prime adaptive immune response, we show for the first time, through in vivo pulmonary studies in mice, that HD-Ad vectors can prime CD4(+) and CD8(+) T cell responses in the lung at high and substantially low doses. This indicates cross-presentation of HD-Ad-derived epitopes by DCs to prime CD8(+) T cell responses. To assess the basis of pulmonary T cell response against HD-Ad vectors, we examined the response of conventional DCs (cDCs) and plasmacytoid DCs (pDCs) in the lung. In response to HD-Ad delivery, there is induction of maturation in both cDC and pDC subsets, but it is the cDCs, not pDCs, that migrate rapidly to draining lymph nodes within the first 2 days after vector delivery to prime adaptive immune response against these vectors. These findings have implications for development of strategies to prevent adaptive immune responses against gene therapy vectors.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
180
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4098-108
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:18322220-Adenoviridae,
pubmed-meshheading:18322220-Adenoviridae Infections,
pubmed-meshheading:18322220-Administration, Intranasal,
pubmed-meshheading:18322220-Animals,
pubmed-meshheading:18322220-Bone Marrow Cells,
pubmed-meshheading:18322220-Cell Differentiation,
pubmed-meshheading:18322220-Cell Movement,
pubmed-meshheading:18322220-Cell Proliferation,
pubmed-meshheading:18322220-Cells, Cultured,
pubmed-meshheading:18322220-Dendritic Cells,
pubmed-meshheading:18322220-Genetic Vectors,
pubmed-meshheading:18322220-Helper Viruses,
pubmed-meshheading:18322220-Immunity, Innate,
pubmed-meshheading:18322220-Lung,
pubmed-meshheading:18322220-Mice,
pubmed-meshheading:18322220-Mice, Inbred C57BL,
pubmed-meshheading:18322220-T-Lymphocyte Subsets
|
pubmed:year |
2008
|
pubmed:articleTitle |
Characterization of pulmonary T cell response to helper-dependent adenoviral vectors following intranasal delivery.
|
pubmed:affiliation |
Physiology and Experimental Medicine Research Program, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|